Cargando…

Deleting Death and Dialysis: Conservative Care of Cardio-Vascular Risk and Kidney Function Loss in Chronic Kidney Disease (CKD)

The uremic syndrome, which is the clinical expression of chronic kidney disease (CKD), is a complex amalgam of accelerated aging and organ dysfunctions, whereby cardio-vascular disease plays a capital role. In this narrative review, we offer a summary of the current conservative (medical) treatment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vanholder, Raymond, Van Laecke, Steven, Glorieux, Griet, Verbeke, Francis, Castillo-Rodriguez, Esmeralda, Ortiz, Alberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024824/ https://www.ncbi.nlm.nih.gov/pubmed/29895722 http://dx.doi.org/10.3390/toxins10060237

Ejemplares similares

Uraemic toxins and cardiovascular disease: in vitro research versus clinical outcome studies
por: Vanholder, Raymond, et al.
Publicado: (2008)

Contribution of Hypoalbuminemia and Anemia to the Prognostic Value of Plasma p-Cresyl Sulfate and p-Cresyl Glucuronide for Cardiovascular Outcome in Chronic Kidney Disease
por: Verbeke, Francis, et al.
Publicado: (2022)

The intestine and the kidneys: a bad marriage can be hazardous
por: Vanholder, Raymond, et al.
Publicado: (2015)

Soluble Tumor Necrosis Factor Receptor 1 and 2 Predict Outcomes in Advanced Chronic Kidney Disease: A Prospective Cohort Study
por: Neirynck, Nathalie, et al.
Publicado: (2015)

What is new in uremic toxicity?
por: Vanholder, Raymond, et al.
Publicado: (2008)

Chronic Kidney Disease and Fibrosis: The Role of Uremic Retention Solutes
por: Mutsaers, Henricus A. M., et al.
Publicado: (2015)

Determination of Asymmetric and Symmetric Dimethylarginine in Serum from Patients with Chronic Kidney Disease: UPLC-MS/MS versus ELISA
por: Boelaert, Jente, et al.
Publicado: (2016)

Association between Protein-Bound Uremic Toxins and Asymptomatic Cardiac Dysfunction in Patients with Chronic Kidney Disease
por: Chinnappa, Shanmugakumar, et al.
Publicado: (2018)

Urinary output and fractional excretion of sodium and urea as indicators of transient versus intrinsic acute kidney injury during early sepsis
por: Vanmassenhove, Jill, et al.
Publicado: (2013)

Response to Tsikas et al. Comments on Boelaert et al. Determination of Asymmetric and Symmetric Dimethylarginine in Serum from Patients with Chronic Kidney Disease: UPLC–MS/MS versus ELISA. Toxins 2016, 8, 149
por: Boelaert, Jente, et al.
Publicado: (2016)

Influence of severity of illness on neutrophil gelatinase-associated lipocalin performance as a marker of acute kidney injury: a prospective cohort study of patients with sepsis
por: Vanmassenhove, Jill, et al.
Publicado: (2015)

Serum levels of miR-126 and miR-223 and outcomes in chronic kidney disease patients
por: Fourdinier, Ophélie, et al.
Publicado: (2019)

Spontaneous variability of pre-dialysis concentrations of uremic toxins over time in stable hemodialysis patients
por: Eloot, Sunny, et al.
Publicado: (2017)

Syndecan-1 and Free Indoxyl Sulfate Levels Are Associated with miR-126 in Chronic Kidney Disease
por: Fourdinier, Ophélie, et al.
Publicado: (2021)

Prediction of Chronic Kidney Disease Stage 3 by CKD273, a Urinary Proteomic Biomarker
por: Pontillo, Claudia, et al.
Publicado: (2017)

Biochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update
por: Vanholder, Raymond, et al.
Publicado: (2018)

p-Cresyl Sulfate
por: Gryp, Tessa, et al.
Publicado: (2017)

The Effect of ß-Glucan Prebiotic on Kidney Function, Uremic Toxins and Gut Microbiome in Stage 3 to 5 Chronic Kidney Disease (CKD) Predialysis Participants: A Randomized Controlled Trial
por: Ebrahim, Zarina, et al.
Publicado: (2022)

What If Not All Metabolites from the Uremic Toxin Generating Pathways Are Toxic? A Hypothesis
por: Vanholder, Raymond, et al.
Publicado: (2022)

Fasting Ramadan in Chronic Kidney Disease (CKD), Kidney Transplant and Dialysis Patients: Review and Update
por: Habas, Elmukhtar, et al.
Publicado: (2022)

Difference in Profiles of the Gut-Derived Tryptophan Metabolite Indole Acetic Acid between Transplanted and Non-Transplanted Patients with Chronic Kidney Disease
por: Liabeuf, Sophie, et al.
Publicado: (2020)

Homoarginine and Mortality in Pre-Dialysis Chronic Kidney Disease (CKD) Patients
por: Ravani, Pietro, et al.
Publicado: (2013)

Contribution of the uremic milieu to an increased pro-inflammatory monocytic phenotype in chronic kidney disease
por: Borges Bonan, Natalia, et al.
Publicado: (2019)

When to start dialysis in patients with acute kidney injury? When semantics and logic become entangled with expectations and beliefs
por: Lameire, Norbert, et al.
Publicado: (2011)

Development of a MALDI MS‐based platform for early detection of acute kidney injury
por: Carrick, Emma, et al.
Publicado: (2016)

Gut-Derived Metabolites and Their Role in Immune Dysfunction in Chronic Kidney Disease
por: Glorieux, Griet, et al.
Publicado: (2020)

Benchmarking CKD: incidence of CKD in a European country with low prevalence of CKD and kidney replacement therapy
por: Ortiz, Alberto
Publicado: (2022)

Transcriptome Analysis in Patients with Chronic Kidney Disease on Hemodialysis Disclosing a Key Role for CD16(+)CX3CR1(+) Monocytes
por: Schepers, Eva, et al.
Publicado: (2015)

Estimated Glomerular Filtration Rate Is a Poor Predictor of the Concentration of Middle Molecular Weight Uremic Solutes in Chronic Kidney Disease
por: Neirynck, Nathalie, et al.
Publicado: (2012)

Uraemic toxins and new methods to control their accumulation: game changers for the concept of dialysis adequacy
por: Glorieux, Griet, et al.
Publicado: (2015)

Effects of Fecal Microbiota Transplantation on Composition in Mice with CKD
por: Barba, Christophe, et al.
Publicado: (2020)

Looking beyond endotoxin: a comparative study of pyrogen retention by ultrafilters used for the preparation of sterile dialyis fluid
por: Glorieux, Griet, et al.
Publicado: (2014)

Where and When To Inject Low Molecular Weight Heparin in Hemodiafiltration? A Cross Over Randomised Trial
por: Dhondt, Annemieke, et al.
Publicado: (2015)

Editorial: Management of Patients With Non-dialysis Dependent Chronic Kidney Disease (ND-CKD)
por: Provenzano, Michele, et al.
Publicado: (2022)

Does the Adequacy Parameter Kt/V(urea) Reflect Uremic Toxin Concentrations in Hemodialysis Patients?
por: Eloot, Sunny, et al.
Publicado: (2013)

Gut Microbiome Profiling Uncovers a Lower Abundance of Butyricicoccus in Advanced Stages of Chronic Kidney Disease
por: Gryp, Tessa, et al.
Publicado: (2021)

Pro/con debate: Continuous versus intermittent dialysis for acute kidney injury: a never-ending story yet approaching the finish?
por: Vanholder, Raymond, et al.
Publicado: (2011)

Impact of Vitamin D on the Cardiovascular System in Advanced Chronic Kidney Disease (CKD) and Dialysis Patients
por: Gluba-Brzózka, Anna, et al.
Publicado: (2018)

Dialysis Initiation in Patients With Chronic Coronary Disease and Advanced Chronic Kidney Disease in ISCHEMIA‐CKD
por: Briguori, Carlo, et al.
Publicado: (2022)

Obesity and Other Nutrition Related Abnormalities in Pre-Dialysis Chronic Kidney Disease (CKD) Participants
por: Ebrahim, Zarina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hvr8rfsihh9250ju3tu25r1fg3